POLYNUCLEOTIDES ENCODING BREX SYSTEM POLYPEPTIDES AND METHODS OF USING S AME
    2.
    发明申请
    POLYNUCLEOTIDES ENCODING BREX SYSTEM POLYPEPTIDES AND METHODS OF USING S AME 审中-公开
    编码BREX系统聚合物的多核苷酸和使用SME的方法

    公开(公告)号:WO2015059690A1

    公开(公告)日:2015-04-30

    申请号:PCT/IL2014/050902

    申请日:2014-10-14

    Abstract: Isolated polynucleotides encoding a BREX system are provided. Accordingly there is provided an isolated polynucleotide encoding a BREX system comprising a nucleic acid sequence encoding the BREX system comprising brxC/pglY, pglZ and at least one of pglX, pglXI, brxP, brxHI, brxHH, brxL, brxD, brxA, brxB, brxF , and brxE , with the proviso that said BREX system does not comprise pglW , and wherein said BREX system confers phage resistance to a bacteria recombinantiy expressing same; Also provided is an isolated polynucleotide encoding a BREX system comprising a nucleic acid sequence encoding the BREX system comprising brxC/pglY, pglZ, pglX, pglW and at least one of brxD and brxHI , and wherein said BREX system confers phage resistance to a bacteria recombinantiy expressing same. Also provided are compositions and methods for conferring phage resistance to bacteria or for conferring bacterial susceptibility to phages.

    Abstract translation: 提供编码BREX系统的分离的多核苷酸。 因此,提供了编码BREX系统的分离的多核苷酸,其包含编码BREX系统的核酸序列,其包含brxC / pglY,pglZ和pglX,pglXI,brxP,brxHI,brxHH,brxL,brxD,brxA,brxB,brxF中的至少一种 和brxE,条件是所述BREX系统不包含pglW,并且其中所述BREX系统赋予对表达其的重组细菌的噬菌体抗性; 还提供了编码BREX系统的分离的多核苷酸,其包含编码包含brxC / pglY,pglZ,pglX,pglW和至少一种brxD和brxHI的BREX系统的核酸序列,并且其中所述BREX系统赋予对重组细菌的噬菌体抗性 表达相同。 还提供了赋予细菌噬菌体抗性或赋予细菌对噬菌体易感性的组合物和方法。

    COMPOSITIONS AND METHODS FOR DOWNREGULATING PROKARYOTIC GENES
    6.
    发明申请
    COMPOSITIONS AND METHODS FOR DOWNREGULATING PROKARYOTIC GENES 审中-公开
    用于下调原核生物基因的组合物和方法

    公开(公告)号:WO2012164565A1

    公开(公告)日:2012-12-06

    申请号:PCT/IL2012/050194

    申请日:2012-05-31

    Abstract: An isolated polynucleotide is disclosed. The polynucleotide comprises a clustered, regularly interspaced short palindromic repeat (CRISPR) array nucleic acid sequence wherein at least one spacer of the CRISPR is sufficiently complementary to a portion of at least one prokaryotic gene so as to down-regulate expression of the prokaryotic gene and further comprises a nucleic acid sequence encoding at least one CRISPR associated (CAS) polypeptide of a repeat associated mysterious protein (RAMP) family. Uses of the polynucleotides and pharmaceutical compositions comprising the polynucleotides are also disclosed.

    Abstract translation: 公开了一种分离的多核苷酸。 多核苷酸包含聚集的,规则间隔的短回文重复(CRISPR)阵列核酸序列,其中CRISPR的至少一个间隔基与至少一个原核基因的一部分充分互补,以便下调原核基因的表达, 还包含编码重复相关神经蛋白(RAMP)家族的至少一种CRISPR相关(CAS)多肽的核酸序列。 还公开了包含多核苷酸的多核苷酸和药物组合物的用途。

    ANTI-VIRAL AND ANTI-TUMORAL COMPOUNDS
    7.
    发明申请

    公开(公告)号:WO2020202142A2

    公开(公告)日:2020-10-08

    申请号:PCT/IL2020/050377

    申请日:2020-03-29

    Abstract: Disclosed herein are prokaryotic homologs of viperin (pVips), and nucleotide and nucleoside analogs produced from pVips. These nucleotide and nucleoside analogs stop nucleotide chain synthesis and provide host cells with resistance to viral infections by targeting actively replicating viral genome. Further, these nucleotide and nucleoside analogs decrease DNA replication in malignant cells. Further disclosed are methods of identifying pVips, and nucleotide and nucleoside analogs produced thereof.

Patent Agency Ranking